Asset

Clindamycin Phosphate

Smith & Nephew SNATS Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (2)

ApplicationTypeApplicant
ANDA 062819ANDASOLOPAK LABORATORIES INC
ANDA 062852ANDASOLOPAK LABORATORIES INC

Marketed products (2)

  • CLINDAMYCIN PHOSPHATE
  • CLINDAMYCIN PHOSPHATE